1 study found for:    Open Studies | "Kernicterus"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Determining Prevalence of Acute Bilirubin Encephalopathy in Developing Countries
Conditions: Demonstrate BIND II Score of >=5, is Valid for Detecting Moderate to Severe ABE in Neonates <14 Days Old.;   Demonstrate Community-BIND Instrument, a Modified BIND II, is a Valid and Reliable Tool for Detecting ABE.;   Demonstrate That Community-BIND Can be Used for Acquiring Population-based Prevalence of ABE in the Community.
Intervention:

Indicates status has not been verified in more than two years